Alykhan Shamji joined the Broad Institute as the Associate Director of the Chemical Biology Program in 2007. He works closely with Broad investigators interested in applying chemical biology approaches to advance the mission of the institute: accelerating the understanding and treatment of disease. He leads a research group in this area, and oversees the financial and operational administration of the program.
His work focuses on the discovery and characterization of small molecules with potential to impact disease research and medicine. Working with the scientific community, his group aims to understand the relationship between disease genetics, pathophysiology, and the response to small molecules, with the goal of defining and testing strategies for therapeutic intervention. His projects focus on cancer, diabetes, and inflammatory bowel disease.
Before joining the Broad, Shamji was a management consultant at the Boston Consulting Group, focusing on pharmaceuticals, clinical diagnostics, and strategic acquisitions. He received both his A.B. in biochemical sciences and his Ph.D. in biophysics from Harvard University.